Obligatory requirement for antibody in recovery from a primary poxvirus infection - Wikidata - wikimedia - TriplyDB

Obligatory requirement for antibody in recovery from a primary poxvirus infection

Obligatory requirement for antibody in recovery from a primary poxvirus infection

http://www.wikidata.org/entity/Q34717009

about

Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection Evidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve Mice Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection A role for NKG2D in NK cell-mediated resistance to poxvirus disease.Surviving mousepox infection requires the complement system A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.The poxvirus A35 protein is an immunoregulator Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice The immunology of smallpox vaccines.Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.A quantitative rabbit model of vaccinia keratitis.A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.Smallpox vaccines: targets of protective immunity.Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Cowpox virus induces interleukin-10 both in vitro and in vivo Immune modulation in primary vaccinia virus zoonotic human infections Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.Correlates of protective immunity in poxvirus infection: where does antibody stand?Evolutionary struggles between NK cells and viruses.Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques Increased per cell IFN-gamma productivity indicates recent in vivo activation of T cells.The smallpox vaccine induces an early neutralizing IgM response.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.Defending against smallpox: a focus on vaccines.Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.Serologic and Molecular Evidence of Vaccinia Virus Circulation among Small Mammals from Different Biomes, Brazil.

P2860

Q27313373-DE7CBFC7-C521-43F4-BBDB-B1B8F96937D8 Q27316583-28A2E429-2C2F-4626-B506-EFC681BFB7BF Q27346800-2B28DDAF-1FA4-4A74-843D-81A981F94503 Q27346933-B8B4BF05-B139-421C-8138-FAF712D10F8B Q28748570-81C0B801-DF37-4577-9E38-DCAEC721D9C7 Q33302672-34D504FB-BE15-4F9A-83B9-6AB5808F1AB5 Q33319278-5711B1B8-E1A7-4203-81DC-58750C02D05E Q33396210-866AF314-D9C8-48A7-8A83-2708843926AB Q33429965-6BA97761-5A35-4869-A2ED-993FAC1A93A3 Q33558734-EF81887F-B080-453F-872A-72521235D87F Q33639966-AEEE5C39-336F-469F-B828-627BD7F70E7C Q33679943-56860F5E-8AD2-444E-B949-250AC810534C Q34120177-74426297-F417-4358-9E10-D3F5FDD85601 Q34135490-A8BCF5C3-276E-4948-A666-DFD151DED733 Q34206208-0B476AFE-9352-472E-90BB-220E34981EB4 Q34243319-6BB7823B-4D30-4F70-9124-B132990A047C Q34716960-855850E9-678E-42DF-A0A2-A034A42A7DBF Q34742613-B8FFF6D4-D88B-42AB-98A7-C708D03AC89A Q34780607-41F30D2B-E3CB-43B8-A8A8-0011A020B1EC Q34810232-274A7359-D3FF-42EF-8060-2ED9CB135D9D Q34991389-B410C9E6-097E-471B-A9C1-A3D363474AB1 Q35206861-066C967B-76ED-4E31-AFDE-37AEE9286F01 Q35539329-F67B1BE9-8F20-44F6-A53E-D8E29AF64B86 Q35645804-670AA1B5-2614-4055-8082-C61732A9EB03 Q35738585-4C2CFF32-EB38-417F-AD28-FA241438CED6 Q35784998-7A16EE03-1C1E-47EE-9603-6B4D20EDFBEB Q36056478-5F3BC434-DB8D-402A-A21B-4540DCF92242 Q36155548-4D4C3542-6B70-4914-8E57-60B37463BA0D Q36155569-3D857089-5F16-44B0-BBDB-C9AF7E51BEB1 Q36965655-24F21A80-8717-44D8-B756-7022B698CF9E Q36976220-5B73E283-659C-4AFC-8F05-5D4E44D60F3D Q37107609-D8BFE665-F822-43FA-A72F-D057418A3187 Q37211164-5BC3538C-C0DB-4D66-824D-8307C201761F Q37251764-EA62C1F9-A3A3-4489-B221-26593724FCE3 Q37456873-EF1AF579-CDB8-4179-BBAC-52457E1F4E02 Q37791160-51D5387A-3BEF-4333-9466-844C9C7098FB Q38799357-8AB79838-D585-41A5-93CC-AD79DAA02CBA Q39667525-B2ADDF2A-21AC-4323-B0AF-0A08A9A85758 Q39916149-04C898CC-680A-4DA3-999D-1E1A50641AAF Q40197144-ACFD6922-CF92-4C37-B009-070A760B2EC1

P2860

Obligatory requirement for antibody in recovery from a primary poxvirus infection

http://www.wikidata.org/entity/Q34717009

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@ast

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@en

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@nl

type

label

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@ast

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@en

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@nl

prefLabel

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@ast

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@en

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@nl

P1433

Q34717009-D8835266-1567-444A-BCCF-CFF2D9CF9278

P1476

Q34717009-1C38270A-0106-4E74-9BBE-FC6BBF064F21

P2093

Q34717009-002454C6-0C1A-49CA-A875-7DD6E24558BC

Q34717009-0F0D9735-842A-49B8-8AB4-A3D56B6001EA

Q34717009-2B26B5B9-0A0A-4403-B3A1-7F993D23B57F

Q34717009-C6451727-D3BF-4C53-AA0E-7591FB953CAE

P2860

Q34717009-00A43C08-04BE-4866-A038-3F44690837F7

Q34717009-0411D017-D52B-44CE-89FF-D8605E71C085

Q34717009-0AD6C16E-317D-4BB6-8287-CE6E98755468

Q34717009-0BB2CD44-0309-4DBD-A888-FE1004F18F16

Q34717009-0F1C25DB-6C60-47D0-A735-42AC3D5054CA

Q34717009-1A63CFC7-4C99-470D-9FEF-345BCF9B10B5

Q34717009-1E2DCEEA-6888-4906-ABBA-8D9DF474DAA7

Q34717009-2C6FDC58-A17C-40D0-9B0F-B24464063B30

Q34717009-2D7525A1-DCAA-4CCA-82F2-7B8F840B9B89

Q34717009-34B7692E-086B-4EBB-9F83-96EBFE157308

P304

Q34717009-604AB06D-41A3-4847-AD40-160699C717C6

P31

Q34717009-6561A94D-9743-422E-AEE7-5A180A048942

P356

Q34717009-57838463-A33E-439F-81FE-FA34D552B161

P407

Q34717009-473B01AD-09EB-4A1E-91BE-6F34813B16CF

P433

Q34717009-EF054281-BD64-43FB-A82D-62AD80197D3A

P478

Q34717009-2B4B257B-7C84-449D-A9B2-A6DD3A6C2304

P577

Q34717009-BF77DA3B-4806-484D-82BE-ADB1B06EA24B

P698

Q34717009-5FE6E5E4-E4B5-497D-A6CE-6C6AAD69ED52

P921

Q34717009-9B4988FD-E5FF-49AE-97D9-C3D26860E1D6

P932

Q34717009-A50262F2-9C6C-4351-90FB-7B48DA46F23F

P356

P1433

Journal of Virology

P1476

Obligatory requirement for antibody in recovery from a primary poxvirus infection

@en

P2093

Geeta Chaudhri

http://www.w3.org/2001/XMLSchema#string

Gunasegaran Karupiah

http://www.w3.org/2001/XMLSchema#string

Horst Bluethmann

http://www.w3.org/2001/XMLSchema#string

Vijay Panchanathan

http://www.w3.org/2001/XMLSchema#string

P2860

Smallpox as a Biological Weapon

Poxvirus pathogenesis

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

Perforin is essential for control of ectromelia virus but not related poxviruses in mice.

Techniques for studying murine natural killer cells in defense against viral infection.

Interferon function is not required for recovery from a secondary poxvirus infection.

T cell-dependent B cell activation.

Cell-mediated cytotoxicity in recovery from poxvirus infections.

P304

6339-6344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00116-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16775322

http://www.w3.org/2001/XMLSchema#string

P921

P932

1488964

http://www.w3.org/2001/XMLSchema#string